ELITE PHARMACEUTICALS INC /NV/ - Recent Material Event

Item 2.02. Results of Operations and Financial Condition.

 

On August 14, 2012 the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

Exhibit 99.1.         Press Release dated August 14, 2012.

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: August 14, 2012

 

  ELITE PHARMACEUTICALS, INC.
   
  By: /s/ Chris Dick
  Name: Chris Dick
  Title: President & Chief Operating Officer